Previous Close | 4.3100 |
Open | 4.2200 |
Bid | 3.9900 x 200 |
Ask | 4.0300 x 100 |
Day's Range | 3.9200 - 4.3699 |
52 Week Range | 0.3370 - 5.6700 |
Volume | |
Avg. Volume | 774,312 |
Market Cap | 207.569M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
WASHINGTON, June 06, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or “ASPI” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, announced today the closing of an additional offering of convertible notes by ASPI’s wholly-owned subsidiary, Quantum Leap Energy LLC ("QLE”). Approximately $5.4 million aggregate principal amount of QLE’s convertible notes (the
- Purchase order covers supply of highly enriched silicon-28, which is expected to be supplied in 2024. - This purchase order is the second order for the supply of enriched electronic gases in 2024. - The Company is in discussions with multiple potential customers regarding the supply of highly enriched isotopically pure electronic gases for next-generation semiconductors, anticipated to enable technologies such as quantum computing and artificial intelligence. WASHINGTON, June 03, 2024 (GLOBE N
ORLANDO, FL / ACCESSWIRE / May 24, 2024 / RedChip Companies will air interviews with ASP Isotopes Inc. (Nasdaq:ASPI) and Calidi Biotherapeutics Inc. (NYSE American:CLDI) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg ...